Authors: Brophy, DF Wazny, LD Gehr, TWB Comstock, TJ Venitz, J

Citation: Df. Brophy et al., Low-molecular-weight heparin administration in patients with end-stage renal disease - Author's reply, PHARMACOTHE, 21(8), 2001, pp. 1017-1019

Authors: Brophy, DF Wazny, LD Gehr, TWB Comstock, TJ Venitz, J

Citation: Df. Brophy et al., The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease, PHARMACOTHE, 21(2), 2001, pp. 169-174

Authors: Hudson, JQ Comstock, TJ

Citation: Jq. Hudson et Tj. Comstock, Considerations for optimal iron use for anemia due to chronic kidney disease, CLIN THER, 23(10), 2001, pp. 1637-1671

Authors: Matzke, GR St Peter, WL Comstock, TJ Foote, EF

Citation: Gr. Matzke et al., Nephrology pharmaceutical care preceptorship: A programmatic and clinical outcomes assessment, ANN PHARMAC, 34(5), 2000, pp. 593-599